202 related articles for article (PubMed ID: 32948799)
1. Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes.
Nicks AM; Kesteven SH; Li M; Wu J; Chan AY; Naqvi N; Husain A; Feneley MP; Smith NJ; Iismaa SE; Graham RM
Sci Rep; 2020 Sep; 10(1):15318. PubMed ID: 32948799
[TBL] [Abstract][Full Text] [Related]
2. Rats are protected from the stress of chronic pressure overload compared with mice.
Nishimura K; Oydanich M; Zhang J; Babici D; Fraidenraich D; Vatner DE; Vatner SF
Am J Physiol Regul Integr Comp Physiol; 2020 May; 318(5):R894-R900. PubMed ID: 32209023
[TBL] [Abstract][Full Text] [Related]
3. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
4. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
[TBL] [Abstract][Full Text] [Related]
5. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
8. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
9. O-ring-induced transverse aortic constriction (OTAC) is a new simple method to develop cardiac hypertrophy and heart failure in mice.
Nakao Y; Aono J; Hamaguchi M; Takahashi K; Sakaue T; Inoue K; Ikeda S; Yamaguchi O
Sci Rep; 2022 Jan; 12(1):85. PubMed ID: 34997065
[TBL] [Abstract][Full Text] [Related]
10. c-kit is required for cardiomyocyte terminal differentiation.
Li M; Naqvi N; Yahiro E; Liu K; Powell PC; Bradley WE; Martin DI; Graham RM; Dell'Italia LJ; Husain A
Circ Res; 2008 Mar; 102(6):677-85. PubMed ID: 18258857
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
12. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy.
Røe ÅT; Aronsen JM; Skårdal K; Hamdani N; Linke WA; Danielsen HE; Sejersted OM; Sjaastad I; Louch WE
Cardiovasc Res; 2017 Aug; 113(10):1161-1172. PubMed ID: 28472418
[TBL] [Abstract][Full Text] [Related]
13. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.
Ichinose F; Bloch KD; Wu JC; Hataishi R; Aretz HT; Picard MH; Scherrer-Crosbie M
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1070-5. PubMed ID: 14644766
[TBL] [Abstract][Full Text] [Related]
14. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
[TBL] [Abstract][Full Text] [Related]
15. Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice.
Iismaa SE; Li M; Kesteven S; Wu J; Chan AY; Holman SR; Calvert JW; Haq AU; Nicks AM; Naqvi N; Husain A; Feneley MP; Graham RM
Sci Rep; 2018 Apr; 8(1):6114. PubMed ID: 29666426
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice.
Marano G; Palazzesi S; Vergari A; Catalano L; Gaudi S; Testa C; Canese R; Carpinelli G; Podo F; Ferrari AU
Pflugers Arch; 2003 Jul; 446(4):429-36. PubMed ID: 12715181
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin ligase
Snyder LB; Lai Y; Doviak H; Freeburg LA; Laney VK; Moore A; Zellars KN; Matesic LE; Spinale FG
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H976-H984. PubMed ID: 34559578
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.
Buys ES; Raher MJ; Blake SL; Neilan TG; Graveline AR; Passeri JJ; Llano M; Perez-Sanz TM; Ichinose F; Janssens S; Zapol WM; Picard MH; Bloch KD; Scherrer-Crosbie M
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H620-7. PubMed ID: 17416602
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
